The wearable cardiac devices market size has grown rapidly in recent years. It will grow from $5.65 billion in 2025 to $6.73 billion in 2026 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to limited availability of advanced cardiac monitoring technology, rising incidence of cardiovascular diseases, dependence on hospital-based monitoring, high cost of early wearable devices, lack of consumer awareness about wearable cardiac devices.
The wearable cardiac devices market size is expected to see rapid growth in the next few years. It will grow to $13.42 billion in 2030 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to miniaturization of sensors and devices, increasing adoption of remote patient monitoring solutions, integration with smartphones and digital health platforms, rising health consciousness among consumers, expansion of reimbursement policies for wearable cardiac devices. Major trends in the forecast period include growing adoption of wearable cardiac devices for remote patient monitoring, increasing integration of ecg and heart rate monitoring features, rising use of wearable defibrillators for sudden cardiac arrest prevention, expansion of consumer-focused fitness and wellness devices, development of wireless and disposable cardiac monitoring patches.
The rising incidence of cardiovascular diseases is anticipated to drive the expansion of the wearable cardiac devices market in the coming years. Modifiable risk factors for cardiovascular disease include high blood pressure, unhealthy dietary habits, increased LDL cholesterol levels, lack of physical activity, and certain environmental exposures, all of which contribute to conditions such as coronary artery disease, heart failure, stroke, and hypertension. Wearable cardiac devices play an important role in public health by enabling continuous, real-time monitoring of cardiac activity, supporting early identification and management of these risk factors, and reducing the likelihood of severe cardiovascular events through ongoing tracking of key parameters such as heart rate, cardiac rhythm, and electrical signals. For example, in October 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2023 cardiovascular disease was responsible for 919,032 deaths, representing nearly one in every three deaths. Coronary heart disease continued to be the most common type of heart disease, and notably, approximately one in six cardiovascular-related deaths occurred among adults under the age of 65. As a result, the growing prevalence of cardiovascular diseases is contributing significantly to the growth of the wearable cardiac devices market.
Leading companies in the wearable cardiac device market are increasingly concentrating on the development of advanced offerings, including extended-wear, AI-enabled ECG patches, to support continuous remote heart monitoring, enable early identification of arrhythmias, and promote home-based cardiac care. These extended-wear AI-enabled ECG patches are slim, flexible adhesive devices applied to the chest that continuously capture the heart’s electrical signals over several days (such as up to two weeks) and use integrated biosensors combined with AI-powered analytics to identify arrhythmias more effectively than conventional Holter monitors. For example, in September 2023, iRhythm Technologies, a U.S.-based digital health company, introduced its next-generation Zio monitor, described as the smallest, lightest, and thinnest cardiac patch monitor within its Zio long-term continuous monitoring (LTCM) service. The Zio monitor enables up to 14 days of uninterrupted ECG monitoring, incorporates a breathable and waterproof design with hydrocolloid adhesive, and integrates with iRhythm’s ZEUS AI software to improve arrhythmia detection efficiency, thereby enhancing patient comfort and increasing diagnostic accuracy.
In May 2024, WearLinq Inc., a US-based digital health firm specializing in wearable cardiac technology, acquired AMI Cardiac Monitoring LLC for an undisclosed price. Through this acquisition, WearLinq aimed to expand its clinical services across the US by combining AMI’s diagnostic expertise with its FDA 510(k)-cleared 6-lead ECG wearable device. AMI Cardiac Monitoring LLC is a US-based company known for offering the WearLinq eWave, a wireless 6-lead cardiac monitor designed to provide both patient comfort and clinical accuracy.
Major companies operating in the wearable cardiac devices market are Apple Inc., Samsung Electronics Co. Ltd., Abbott Laboratories, Medtronic plc, Garmin Ltd., Masimo Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Biofourmis, Bittium Corporation, BPL Medical Technologies Pvt. Ltd., NeuroSky Inc., Bionet Co. Ltd., AliveCor Inc., Qardio Inc., Empatica Inc., VitalConnect Inc., Lifesignals Group, Biotricity Inc., Shimmer Research.
North America was the largest region in the wearable cardiac devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable cardiac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wearable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the wearable cardiac devices market by raising the cost of imported electronic components, sensors, and manufacturing equipment, resulting in increased production costs for device manufacturers. Segments such as smartwatches, wearable defibrillators, and advanced ECG-enabled patches are most affected, particularly in regions like Asia-Pacific and North America, which rely heavily on cross-border component supply chains. While tariffs create pricing pressures, they also incentivize local manufacturing, encourage regional innovation, and support the development of cost-optimized devices for domestic and global markets.
The wearable cardiac devices market research report is one of a series of new reports that provides wearable cardiac devices market statistics, including wearable cardiac devices industry global market size, regional shares, competitors with a wearable cardiac devices market share, detailed wearable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable cardiac devices industry. This wearable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Wearable cardiac devices are electronic medical tools that continuously track heart activity, including heart rate and rhythm, through built-in sensors. These devices can identify irregular heartbeats and, in certain cases, automatically deliver therapeutic electrical shocks to restore normal rhythm in patients at risk of sudden cardiac arrest.
The primary types of wearable cardiac devices include Holter monitors, smartwatches, patches, defibrillators, pulse oximeters, and other related products. A Holter monitor is a compact, wearable device that records heart activity continuously for 24-48 hours to detect irregular rhythms during everyday activities. These devices serve multiple purposes such as arrhythmia detection, heart rate monitoring, and managing heart diseases. They are distributed via both online and offline channels and are used by a range of end users including hospitals, clinics, individual consumers, and fitness centers.
The wearable cardiac devices market consists of sales of insertable cardiac monitors (ICMS), wearable ECG t-shirts, smart garments, chest strap ECG monitors, continuous blood pressure monitors, wearable telemetry devices, smart rings, ECG-enabled hearing aids, and ECG-enabled earbuds. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The wearable cardiac devices market size is expected to see rapid growth in the next few years. It will grow to $13.42 billion in 2030 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to miniaturization of sensors and devices, increasing adoption of remote patient monitoring solutions, integration with smartphones and digital health platforms, rising health consciousness among consumers, expansion of reimbursement policies for wearable cardiac devices. Major trends in the forecast period include growing adoption of wearable cardiac devices for remote patient monitoring, increasing integration of ecg and heart rate monitoring features, rising use of wearable defibrillators for sudden cardiac arrest prevention, expansion of consumer-focused fitness and wellness devices, development of wireless and disposable cardiac monitoring patches.
The rising incidence of cardiovascular diseases is anticipated to drive the expansion of the wearable cardiac devices market in the coming years. Modifiable risk factors for cardiovascular disease include high blood pressure, unhealthy dietary habits, increased LDL cholesterol levels, lack of physical activity, and certain environmental exposures, all of which contribute to conditions such as coronary artery disease, heart failure, stroke, and hypertension. Wearable cardiac devices play an important role in public health by enabling continuous, real-time monitoring of cardiac activity, supporting early identification and management of these risk factors, and reducing the likelihood of severe cardiovascular events through ongoing tracking of key parameters such as heart rate, cardiac rhythm, and electrical signals. For example, in October 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2023 cardiovascular disease was responsible for 919,032 deaths, representing nearly one in every three deaths. Coronary heart disease continued to be the most common type of heart disease, and notably, approximately one in six cardiovascular-related deaths occurred among adults under the age of 65. As a result, the growing prevalence of cardiovascular diseases is contributing significantly to the growth of the wearable cardiac devices market.
Leading companies in the wearable cardiac device market are increasingly concentrating on the development of advanced offerings, including extended-wear, AI-enabled ECG patches, to support continuous remote heart monitoring, enable early identification of arrhythmias, and promote home-based cardiac care. These extended-wear AI-enabled ECG patches are slim, flexible adhesive devices applied to the chest that continuously capture the heart’s electrical signals over several days (such as up to two weeks) and use integrated biosensors combined with AI-powered analytics to identify arrhythmias more effectively than conventional Holter monitors. For example, in September 2023, iRhythm Technologies, a U.S.-based digital health company, introduced its next-generation Zio monitor, described as the smallest, lightest, and thinnest cardiac patch monitor within its Zio long-term continuous monitoring (LTCM) service. The Zio monitor enables up to 14 days of uninterrupted ECG monitoring, incorporates a breathable and waterproof design with hydrocolloid adhesive, and integrates with iRhythm’s ZEUS AI software to improve arrhythmia detection efficiency, thereby enhancing patient comfort and increasing diagnostic accuracy.
In May 2024, WearLinq Inc., a US-based digital health firm specializing in wearable cardiac technology, acquired AMI Cardiac Monitoring LLC for an undisclosed price. Through this acquisition, WearLinq aimed to expand its clinical services across the US by combining AMI’s diagnostic expertise with its FDA 510(k)-cleared 6-lead ECG wearable device. AMI Cardiac Monitoring LLC is a US-based company known for offering the WearLinq eWave, a wireless 6-lead cardiac monitor designed to provide both patient comfort and clinical accuracy.
Major companies operating in the wearable cardiac devices market are Apple Inc., Samsung Electronics Co. Ltd., Abbott Laboratories, Medtronic plc, Garmin Ltd., Masimo Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Biofourmis, Bittium Corporation, BPL Medical Technologies Pvt. Ltd., NeuroSky Inc., Bionet Co. Ltd., AliveCor Inc., Qardio Inc., Empatica Inc., VitalConnect Inc., Lifesignals Group, Biotricity Inc., Shimmer Research.
North America was the largest region in the wearable cardiac devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable cardiac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wearable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the wearable cardiac devices market by raising the cost of imported electronic components, sensors, and manufacturing equipment, resulting in increased production costs for device manufacturers. Segments such as smartwatches, wearable defibrillators, and advanced ECG-enabled patches are most affected, particularly in regions like Asia-Pacific and North America, which rely heavily on cross-border component supply chains. While tariffs create pricing pressures, they also incentivize local manufacturing, encourage regional innovation, and support the development of cost-optimized devices for domestic and global markets.
The wearable cardiac devices market research report is one of a series of new reports that provides wearable cardiac devices market statistics, including wearable cardiac devices industry global market size, regional shares, competitors with a wearable cardiac devices market share, detailed wearable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable cardiac devices industry. This wearable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Wearable cardiac devices are electronic medical tools that continuously track heart activity, including heart rate and rhythm, through built-in sensors. These devices can identify irregular heartbeats and, in certain cases, automatically deliver therapeutic electrical shocks to restore normal rhythm in patients at risk of sudden cardiac arrest.
The primary types of wearable cardiac devices include Holter monitors, smartwatches, patches, defibrillators, pulse oximeters, and other related products. A Holter monitor is a compact, wearable device that records heart activity continuously for 24-48 hours to detect irregular rhythms during everyday activities. These devices serve multiple purposes such as arrhythmia detection, heart rate monitoring, and managing heart diseases. They are distributed via both online and offline channels and are used by a range of end users including hospitals, clinics, individual consumers, and fitness centers.
The wearable cardiac devices market consists of sales of insertable cardiac monitors (ICMS), wearable ECG t-shirts, smart garments, chest strap ECG monitors, continuous blood pressure monitors, wearable telemetry devices, smart rings, ECG-enabled hearing aids, and ECG-enabled earbuds. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Wearable Cardiac Devices Market Characteristics
3. Wearable Cardiac Devices Market Supply Chain Analysis
4. Global Wearable Cardiac Devices Market Trends and Strategies
5. Wearable Cardiac Devices Market Analysis of End Use Industries
7. Global Wearable Cardiac Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Wearable Cardiac Devices Total Addressable Market (TAM) Analysis for the Market
9. Wearable Cardiac Devices Market Segmentation
10. Wearable Cardiac Devices Market Regional and Country Analysis
11. Asia-Pacific Wearable Cardiac Devices Market
12. China Wearable Cardiac Devices Market
13. India Wearable Cardiac Devices Market
14. Japan Wearable Cardiac Devices Market
15. Australia Wearable Cardiac Devices Market
16. Indonesia Wearable Cardiac Devices Market
17. South Korea Wearable Cardiac Devices Market
18. Taiwan Wearable Cardiac Devices Market
19. South East Asia Wearable Cardiac Devices Market
20. Western Europe Wearable Cardiac Devices Market
21. UK Wearable Cardiac Devices Market
22. Germany Wearable Cardiac Devices Market
23. France Wearable Cardiac Devices Market
24. Italy Wearable Cardiac Devices Market
25. Spain Wearable Cardiac Devices Market
26. Eastern Europe Wearable Cardiac Devices Market
27. Russia Wearable Cardiac Devices Market
28. North America Wearable Cardiac Devices Market
29. USA Wearable Cardiac Devices Market
30. Canada Wearable Cardiac Devices Market
31. South America Wearable Cardiac Devices Market
32. Brazil Wearable Cardiac Devices Market
33. Middle East Wearable Cardiac Devices Market
34. Africa Wearable Cardiac Devices Market
36. Wearable Cardiac Devices Market Competitive Landscape and Company Profiles
37. Wearable Cardiac Devices Market Other Major and Innovative Companies
40. Wearable Cardiac Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Wearable Cardiac Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses wearable cardiac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for wearable cardiac devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable cardiac devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Holter Monitors; Smartwatches; Patch; Defibrillators; Pulse Oximeters; Other Products2) By Application: Arrhythmia Detection; Heart Rate Monitoring; Heart Disease Management
3) By Distribution Channel: Online; Offline
4) By End User: Hospitals; Clinics; Individual Consumers; Fitness Centers
Subsegments:
1) By Holter Monitors: Single-Channel Holter Monitors; Multi-Channel Holter Monitors; Wireless Holter Monitors2) By Smartwatches: Fitness And Wellness Smartwatches; Medical-Grade Smartwatches; Electrocardiogram (ECG)-Enabled Smartwatches
3) By Patch: Adhesive Cardiac Monitoring Patches; Rechargeable Patch Monitors; Disposable Patch Monitors
4) By Defibrillators: Wearable Cardioverter Defibrillators (WCDs); Automated External Defibrillators (AEDs) With Wearable Integration
5) By Pulse Oximeters: Fingertip Wearable Oximeters; Wrist-Worn Oximeters; Ring-Type Oximeters
6) By Other Products: Chest Straps; Smart Clothing; Portable Electrocardiogram (ECG) Monitors
Companies Mentioned: Apple Inc.; Samsung Electronics Co. Ltd.; Abbott Laboratories; Medtronic plc; Garmin Ltd.; Masimo Corporation; Nihon Kohden Corporation; iRhythm Technologies Inc.; Biofourmis; Bittium Corporation; BPL Medical Technologies Pvt. Ltd.; NeuroSky Inc.; Bionet Co. Ltd.; AliveCor Inc.; Qardio Inc.; Empatica Inc.; VitalConnect Inc.; Lifesignals Group; Biotricity Inc.; Shimmer Research
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Wearable Cardiac Devices market report include:- Apple Inc.
- Samsung Electronics Co. Ltd.
- Abbott Laboratories
- Medtronic plc
- Garmin Ltd.
- Masimo Corporation
- Nihon Kohden Corporation
- iRhythm Technologies Inc.
- Biofourmis
- Bittium Corporation
- BPL Medical Technologies Pvt. Ltd.
- NeuroSky Inc.
- Bionet Co. Ltd.
- AliveCor Inc.
- Qardio Inc.
- Empatica Inc.
- VitalConnect Inc.
- Lifesignals Group
- Biotricity Inc.
- Shimmer Research
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.73 Billion |
| Forecasted Market Value ( USD | $ 13.42 Billion |
| Compound Annual Growth Rate | 18.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
